NCT02818543View on ClinicalTrials.gov

Safety and Pharmacokinetic Study of LYC-30937 in Subjects With Active Ulcerative Colitis

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Ulcerative Colitis
Interventions
DRUG

LYC-30937

Trial Locations (2)

Unknown

DRC Ltd., Balatonfüred

PRA Magyarorszag Kft, Budapest

All Listed Sponsors
lead

Lycera Corp.

INDUSTRY

NCT02818543 - Safety and Pharmacokinetic Study of LYC-30937 in Subjects With Active Ulcerative Colitis | Biotech Hunter | Biotech Hunter